SEC Form 4 · accession 0001615774-17-001106
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregoire Cosendai
Officer — VP of European Operations
Period of report
Mar 14, 2017
Accepted (ET)
Mar 16, 2017 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 14, 2017 | A | 3,366 | $1.47 | A | 10,395 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $1.47 | Mar 14, 2017 | A | 3,366 | A | Mar 14, 2017 | Mar 14, 2022 | Common Stock | 3,366 | 3,366 | D |
| Non-Qualified Stock Option (right to buy)F2 | $1.97 | holding | — | — | — | Jan 3, 2018 | Jan 3, 2027 | Common Stock | 228,190 | 228,190 | D |
| Non-Qualified Stock Option (right to buy)F2 | $4.10 | holding | — | — | — | Jan 21, 2017 | Jan 21, 2026 | Common Stock | 11,513 | 11,513 | D |
| Non-Qualified Stock Option (right to buy)F3 | $5.00 | holding | — | — | — | Nov 1, 2009 | Nov 1, 2018 | Common Stock | 20,000 | 20,000 | D |
| Non-Qualified Stock Option (right to buy)F3 | $5.00 | holding | — | — | — | Feb 1, 2010 | Feb 1, 2019 | Common Stock | 5,081 | 5,081 | D |
| Non-Qualified Stock Option (right to buy)F3 | $5.00 | holding | — | — | — | May 1, 2010 | May 1, 2019 | Common Stock | 10,000 | 10,000 | D |
| Non-Qualified Stock Option (right to buy)F3 | $5.00 | holding | — | — | — | Feb 1, 2011 | Feb 1, 2020 | Common Stock | 14,475 | 14,475 | D |
| Non-Qualified Stock Option (right to buy)F3 | $5.00 | holding | — | — | — | Jun 1, 2011 | Jun 1, 2020 | Common Stock | 2,125 | 2,125 | D |
| Non-Qualified Stock Option (right to buy)F4 | $5.00 | holding | — | — | — | Dec 1, 2011 | Dec 1, 2020 | Common Stock | 25,000 | 25,000 | D |
| Non-Qualified Stock Option (right to buy)F4 | $5.00 | holding | — | — | — | Mar 1, 2012 | Mar 1, 2021 | Common Stock | 6,650 | 6,650 | D |
| Non-Qualified Stock Option (right to buy)F4 | $5.00 | holding | — | — | — | Mar 1, 2013 | Mar 1, 2022 | Common Stock | 7,750 | 7,750 | D |
| Non-Qualified Stock Option (right to buy)F4 | $5.00 | holding | — | — | — | Apr 1, 2015 | Apr 1, 2024 | Common Stock | 10,937 | 10,937 | D |
| Non-Qualified Stock Option (right to buy)F4 | $9.00 | holding | — | — | — | Sep 26, 2015 | Sep 26, 2024 | Common Stock | 51,009 | 51,009 | D |
| Non-Qualified Stock Option (right to buy)F4 | $13.09 | holding | — | — | — | Mar 26, 2016 | Mar 25, 2025 | Common Stock | 6,250 | 6,250 | D |
Explanation of responses
- F1Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017.
- F2Options vest over a four year term of which one-fourth vest on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
- F3Options vest in 5 yearly increments starting with the Date Exercisable
- F4Options vest in 4 yearly increments starting with the Date Exercisable